Rational drug redesign to overcome drug resistance in cancer therapy: imatinib moving target
Cancer research (2007) - Comments
pubmed: 17483313  doi: 10.1158/0008-5472.can-07-0345  issn: 0008-5472  issn: 1538-7445 

Ariel Fernandez, Angela Sanguino, Zhenghong Peng, Alejandro Crespo, Eylem Ozturk, Xi Zhang, Shimei Wang, William Bornmann, Gabriel Lopez-Berestein